Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Non-conservative Management of Chylothorax

  • Ahn, Hyo Yeong (Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • I, Hoseok (Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine)
  • Received : 2021.06.03
  • Accepted : 2021.07.02
  • Published : 2021.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Chylothorax is caused by lymphatic leakage, which can develop after thoracic surgery and is associated with cancer. Although prospective randomized trials have not been performed, radiological interventions have been performed in several cases with persistent chylothorax, adjunct to 2 weeks of conservative management. The success rate of such interventions is diverse due to anatomical variations, although the results are promising. However, in cases of treatment failure after cycles of interventions, a team approach may be necessary to determine whether surgical management is warranted.

Keywords

Acknowledgement

Figs. 1 and 4 were illustrated by Nayun Lee from medical illustrator, Department of Thoracic and Cardioavascular Surgery, Seoul National University Bundang Hospital.

References

  1. Bazancir LA, Jensen RJ, Frevert SC, Ryom P, Achiam MP. Embolization of the thoracic duct in patients with iatrogenic chylothorax. Dis Esophagus 2021 Feb 8 [Epub]. https://doi.org/10.1093/dote/ doab001.
  2. Binkert CA, Yucel EK, Davison BD, Sugarbaker DJ, Baum RA. Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J Vasc Interv Radiol 2005;16:1257-62. https://doi.org/10.1097/01.RVI.0000167869.36093.43
  3. Borcyk K, Kamil A, Hagerty K, Deer M, Tomich P, Anderson Berry AL. Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report. Clin Case Rep 2018;6: 702-8. https://doi.org/10.1002/ccr3.1449
  4. Hara H, Mihara M, Yamamoto M. Therapeutic lymphangiography for traumatic chylothorax. J Vasc Surg Venous Lymphat Disord 2018; 6:237-40. https://doi.org/10.1016/j.jvsv.2017.08.020
  5. Jun H, Hur S. Interventional radiology treatment for postoperative chylothorax. Korean J Thorac Cardiovasc Surg 2020;53:200-4. https://doi.org/10.5090/kjtcs.2020.53.4.200
  6. Juszczyk K, Waugh R, Sandroussi C. Lymphangiography as therapeutic management of chylothorax. J Med Imaging Radiat Oncol 2013;57:460-1. https://doi.org/10.1111/j.1754-9485.2012.02452.x
  7. Schild HH, Strassburg CP, Welz A, Kalff J. Treatment options in patients with chylothorax. Dtsch Arztebl Int 2013;110:819-26.
  8. Schild HH, Pieper C. Chylothorax: current therapeutic options. Zentralbl Chir 2019;144:S24-30. https://doi.org/10.1055/a-0831-2649
  9. Pulle MV, Puri HV, Asaf BB, Bishnoi S, Yadav A, Kumar A. Chylothorax: modalities of management and outcomes: a case series. Lung India 2021;38:154-60. https://doi.org/10.4103/lungindia.lungindia_526_20
  10. Tenny BC, Madjarov J, Shipe T. Surgical intervention in a complicated persistent chyle leak. Int J Surg Case Rep 2018;42:7-9. https://doi.org/10.1016/j.ijscr.2017.11.031
  11. Matsumoto T, Yamagami T, Kato T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009;82:286-90. https://doi.org/10.1259/bjr/64849421
  12. Tapias LF, Morse CR. A preliminary experience with minimally invasive Ivor Lewis esophagectomy. Dis Esophagus 2012;25:449-55. https://doi.org/10.1111/j.1442-2050.2011.01269.x
  13. Varshney VK, Suman S, Garg PK, Soni SC, Khera PS. Management options for post-esophagectomy chylothorax. Surg Today 2021;51: 678-85. https://doi.org/10.1007/s00595-020-02143-y
  14. Jeon YJ, Cho JH, Hyun D, et al. Management of chyle leakage after general thoracic surgery: impact of thoracic duct embolization. Thorac Cancer 2021;12:1382-6. https://doi.org/10.1111/1759-7714.13914
  15. Takuwa T, Yoshida J, Ono S, et al. Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg 2013;146:571-4. https://doi.org/10.1016/j.jtcvs.2013.04.015
  16. Sharkey AJ, Rao JN. The successful use of octreotide in the treatment of traumatic chylothorax. Tex Heart Inst J 2012;39:428-30.
  17. Nadolski GJ, Itkin M. Lymphangiography and thoracic duct embolization following unsuccessful thoracic duct ligation: imaging findings and outcomes. J Thorac Cardiovasc Surg 2018;156:838-43. https://doi.org/10.1016/j.jtcvs.2018.02.109
  18. Sommer CM, Pieper CC, Itkin M, et al. Conventional lymphangiography (CL) in the management of postoperative lymphatic leakage (PLL): a systematic review. Rofo 2020;192:1025-35. https://doi.org/10.1055/a-1131-7889
  19. Jayasinghe SA, Srinivasa RN, Hage AN, Gemmete JJ, Majdalany BS, Chick JF. Thoracic duct embolization: analysis of practice patterns. Ann Vasc Surg 2018;52:168-75. https://doi.org/10.1016/j.avsg.2018.03.016
  20. Kim PH, Tsauo J, Shin JH. Lymphatic interventions for chylothorax: a systematic review and meta-analysis. J Vasc Interv Radiol 2018;29: 194-202. https://doi.org/10.1016/j.jvir.2017.10.006
  21. Lutz P, Strunk H, Schild HH, Sauerbruch T. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J Gastroenterol 2013;19:1140-2. https://doi.org/10.3748/wjg.v19.i7.1140
  22. Arshava EV, Parekh KR. Thoracoscopic thoracic duct ligation: how I teach it. Ann Thorac Surg 2020;109:1330-4. https://doi.org/10.1016/j.athoracsur.2020.01.004
  23. Liu Z, Du M, Liang Y, Ju S, Li X, Gao Y. Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer. Surg Today 2020;50:881-8. https://doi.org/10.1007/s00595-020-01969-w
  24. Yamagata Y, Saito K, Hirano K, Oya M. Laparoscopic transhiatal thoracic duct ligation for chylothorax after esophagectomy. Thorac Cardiovasc Surg 2019;67:606-9. https://doi.org/10.1055/s-0038-1677507
  25. Yang RF, Liu TT, Wang P, et al. Ligation of thoracic duct during thoracoscopic esophagectomy can lead to decrease of T lymphocyte. J Cancer Res Ther 2018;14:1535-9. https://doi.org/10.4103/jcrt.JCRT_596_17
  26. Yamagami T, Masunami T, Kato T, et al. Spontaneous healing of chyle leakage after lymphangiography. Br J Radiol 2005;78:854-7. https://doi.org/10.1259/bjr/61177542